Eli Lilly (LLY) Assets Average (2009 - 2026)
Eli Lilly posted quarterly Assets Average of $114.5 billion for Q1 2026, up 36.26% year-on-year from $84.1 billion in Q1 2025, and up 0.72% on a QoQ basis from $113.7 billion in Q4 2025.
Eli Lilly (LLY) has 18 years of Assets Average data on file, last reported at $114.5 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 36.26% year-over-year to $114.5 billion; the trailing twelve-month figure through Mar 2026 stood at $114.5 billion (up 36.26% YoY), and the FY2025 full-year result was $95.6 billion, up 33.96% from the prior year.
- Assets Average for Q1 2026 stood at $114.5 billion, up from $113.7 billion in the prior quarter.
- Across five years, Assets Average topped out at $114.5 billion in Q1 2026 and bottomed at $47.0 billion in Q2 2022.
- The 5-year median for Assets Average is $64.0 billion (2024), against an average of $71.3 billion.
- The widest annual swing landed in 2022, when Assets Average decreased 1.53%; it then surged 47.36% in 2025.
- A 5-year view of Assets Average shows it stood at $48.5 billion in 2022, then climbed by 25.76% to $61.0 billion in 2023, then advanced by 26.57% to $77.2 billion in 2024, then jumped by 47.36% to $113.7 billion in 2025, then grew by 0.72% to $114.5 billion in 2026.
- The last three Assets Average figures came in at $114.5 billion (Q1 2026), $113.7 billion (Q4 2025), and $107.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 114.53 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 200.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 135.21 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 132.78 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 91.55 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 57.65 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 208.08 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 88.26 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 314.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.53 Bn |
| Dec 31, 2025 | 113.71 Bn |
| Sep 30, 2025 | 107.93 Bn |
| Jun 30, 2025 | 95.16 Bn |
| Mar 31, 2025 | 84.05 Bn |
| Dec 31, 2024 | 77.16 Bn |
| Sep 30, 2024 | 73.74 Bn |
| Jun 30, 2024 | 67.91 Bn |
| Mar 31, 2024 | 63.97 Bn |
| Dec 31, 2023 | 60.96 Bn |
| Sep 30, 2023 | 56.36 Bn |
| Jun 30, 2023 | 53.99 Bn |
| Mar 31, 2023 | 51.33 Bn |
| Dec 31, 2022 | 48.48 Bn |
| Sep 30, 2022 | 47.26 Bn |
| Jun 30, 2022 | 46.99 Bn |
| Mar 31, 2022 | 47.86 Bn |
| Dec 31, 2021 | 48.50 Bn |
| Sep 30, 2021 | 48.00 Bn |
| Jun 30, 2021 | 47.32 Bn |
| Mar 31, 2021 | 46.74 Bn |
| Dec 31, 2020 | 45.29 Bn |
| Sep 30, 2020 | 42.96 Bn |
| Jun 30, 2020 | 41.53 Bn |
| Mar 31, 2020 | 40.19 Bn |
| Dec 31, 2019 | 38.59 Bn |
| Sep 30, 2019 | 38.28 Bn |
| Jun 30, 2019 | 38.34 Bn |
| Mar 31, 2019 | 40.96 Bn |
| Dec 31, 2018 | 44.27 Bn |
| Sep 30, 2018 | 43.49 Bn |
| Jun 30, 2018 | 43.36 Bn |
| Mar 31, 2018 | 44.67 Bn |
| Dec 31, 2017 | 44.00 Bn |
| Sep 30, 2017 | 41.98 Bn |
| Jun 30, 2017 | 39.29 Bn |
| Mar 31, 2017 | 38.22 Bn |
| Dec 31, 2016 | 38.20 Bn |
| Sep 30, 2016 | 37.03 Bn |
| Jun 30, 2016 | 35.58 Bn |
| Mar 31, 2016 | 35.13 Bn |
| Dec 31, 2015 | 35.94 Bn |
| Sep 30, 2015 | 36.17 Bn |
| Jun 30, 2015 | 35.85 Bn |
| Mar 31, 2015 | 35.98 Bn |
| Dec 31, 2014 | 35.48 Bn |
| Sep 30, 2014 | 34.83 Bn |
| Jun 30, 2014 | 34.89 Bn |
| Mar 31, 2014 | 35.00 Bn |
| Dec 31, 2013 | 34.61 Bn |
| Sep 30, 2013 | 33.60 Bn |
| Jun 30, 2013 | 32.76 Bn |
| Mar 31, 2013 | 33.35 Bn |
| Dec 31, 2012 | 34.36 Bn |
| Sep 30, 2012 | 33.07 Bn |
| Jun 30, 2012 | 32.03 Bn |
| Mar 31, 2012 | 32.95 Bn |
| Dec 31, 2011 | 33.35 Bn |
| Sep 30, 2011 | 32.91 Bn |
| Jun 30, 2011 | 32.24 Bn |
| Mar 31, 2011 | 31.35 Bn |
| Dec 31, 2010 | 30.45 Bn |
| Sep 30, 2010 | 28.81 Bn |
| Jun 30, 2010 | 27.46 Bn |
| Mar 31, 2010 | 27.33 Bn |
| Dec 31, 2009 | 23.18 Bn |
| Sep 30, 2009 | 22.91 Bn |